Moneycontrol PRO
HomeNewsSemaglutide

Semaglutide

Jump to
  • Dr Reddy’s: Is the weight loss drug the next big opportunity?

    The company plans to launch the injectable version of Semaglutide in a number of countries, starting with Canada in January 2026. India and Brazil will follow

  • Zydus Lifesciences: Time to accumulate the stock?

    Tariffs pose a near-term risk. However, Zydus’s focus on novel drugs and the foray into medical devices are key moves to watch

  • Cipla: Largely unaffected by the Trump’s executive order

    The medium-term growth drivers include the global rollout of respiratory and GLP-1 drugs.

  • Dr Reddy’s: Watchful of the Revlimid cliff

    In times to come, the company may gear up for new inorganic initiatives to improve its market share in India. In the meantime, margins may moderate

  • Biocon inks licensing pact with Biomm for diabetes management drug Semaglutide in Brazil

    Under the agreement, Biocon will handle the development, manufacturing, and supply of the diabetes management drug, while Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market

  • All you need to know about Mounjaro, the antidiabetic injectable also touted as the most powerful weight-loss drug ever

    The availability of the drug in India may cause a major disruption in the Indian diabetes care drugs market which is expected to register a CAGR greater than 3.5 percent between 2022 and 2027. The COVID-19 pandemic has contributed a major increase in the market.

  • Efforts on to launch once-a week- insulin in India by mid-2025: Novo Nordisk MD

    Danish pharma giant working on launching Icodec. India managing director and corporate vice-president Vikrant Shrotriya says the company also has a plan to launch anti-obesity drug, Wegovy, in India but it may not happen very soon.

  • Fat-busting diabetes drug is a global smash hit but remains prohibitively pricey for many Indians

    Tesla and Twitter owner Elon Musk is the latest celebrity to admit using Wegovy, a higher dose version of Ozempic, for keeping his body "fit, ripped, and healthy”. The drug has caused quite a stir among celebs and influencers over the last several months

  • Anti-Obesity Drug: Science Finally Lets You Lose Weight Without Diet Or Exercise

    Patients with obesity issues may have found a magical drug that will keep them free from grave consequences. A drug named semaglutide suppresses appetite in its fight against obesity and is likely to cut down body weight by 20%.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347